Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Chest-wall and Breast Cancer
NCT04431674 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2023-12-13
Summary
The objective of this study is to demonstrate the feasibility of novel MRI-guided ultrasound stimulated microbubble treatment to enhance radiation effects in humans receiving external beam radiotherapy delivered using a LINAC (linear accelerator) radiation therapy device.
Conditions
Interventions
- DRUG
-
Definity Suspension for Injection
MRI-guided ultrasound-stimulated microbubble-treatment
Sponsors & Collaborators
-
Sunnybrook Health Sciences Centre
lead OTHER
Principal Investigators
-
Dr. Gregory Czarnota, MD · Sunnybrook Health Sciences Centre
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-22
- Primary Completion
- 2023-06-21
- Completion
- 2023-06-21
Countries
- Canada
Study Locations
More Related Trials
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
NCT04368702 ·Status: RECRUITING ·Phase: NA
-
MRG FU With Radiotherapy for Palliation of H&N Cancer
NCT03218475 ·Status: SUSPENDED ·Phase: NA
-
A Phase 1 Study of [225Ac]-FPI-1434 Injection
NCT03746431 ·Status: TERMINATED ·Phase: PHASE1
-
Receiving Radiation Therapy in the MRgRT Research Facility
NCT02701712 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pilot Study to Evaluate Photoacoustic Imaging in Head and Neck Cancer
NCT04428515 ·Status: RECRUITING
-
Hypofractionated Radiotherapy in Breast Cancer
NCT03167359 ·Status: COMPLETED ·Phase: NA
-
Proton Boost for Locally Advanced HEAD AND NECK TUMORS
NCT03183271 ·Status: COMPLETED ·Phase: NA
-
A Phase II Multi-institutional Study Assessing Simultaneous In-field Boost Helical Tomotherapy for 1-3 Brain Metastases
NCT01543542 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca
NCT02453737 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy
NCT04848909 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL)
NCT04135794 ·Status: ACTIVE_NOT_RECRUITING
-
HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers
NCT06487403 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Radiotherapy (SBRT) of Lung Metastasis
NCT01803542 ·Status: RECRUITING ·Phase: PHASE2
-
Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruS
NCT04866394 ·Status: UNKNOWN ·Phase: NA
-
Radiotherapy for Extracranial Oligometastatic Breast Cancer
NCT04646564 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
NCT05985278 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery
NCT04532177 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC
NCT06137274 ·Status: RECRUITING ·Phase: PHASE2
-
Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy
NCT01185145 ·Status: UNKNOWN ·Phase: PHASE2
-
Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging for Lung Cancer Radiotherapy
NCT04310891 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Technological Innovation in Radiotherapy
NCT03378856 ·Status: RECRUITING
-
Comparing SBRT to CRT in Patients With Spinal Metastases
NCT05589701 ·Status: RECRUITING
-
Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy
NCT03042156 ·Status: COMPLETED
-
Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging
NCT02478138 ·Status: COMPLETED ·Phase: NA
-
An Open Label, Single-Centre, Pilot Study of Everolimus With EBRT for the Treatment of mNET Liver Metastasis
NCT02205515 ·Status: COMPLETED ·Phase: PHASE1/PHASE2